- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

Advanced Cell Technology Obtains FDA Approval to Treat Dry AMD with Embryonic Stem Cells

Posted By Irv Arons On January 6, 2011 @ 10:26 am In Industry News,Macular Degeneration,New Technologies,Research,Retina,Stem Cell Therapies | Comments Disabled

Advanced Cell Technology Inc., announced that it  had received approval from the FDA to commence its clinical trial using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs) to treat the dry form of age-related macular degeneration. ACT is now permitted to initiate a Phase I/II multicenter clinical trial to treat patients with dry AMD, the most common form of macular degeneration in the world.

“ACT is now the first company to receive FDA clearance for two hESC trials, and is now a true translational leader in the field of regenerative medicine,” said Gary Rabin, Interim Chairman and CEO of ACT. “It marks a major step forward, not just within the stem cell sector, but, potentially for modern healthcare techniques. We plan to proceed into the clinic with both of our hESC-based programs as quickly as possible.” (For both dry AMD and for treating Stargardt’s Disease, approval for which was obtained in November 2010.)

For the rest of the story see this link [1].


Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/004437-advanced-cell-technology-obtains-fda-approval-to-treat-dry-amd-with-embryonic-stem-cells/

URLs in this post:

[1] link: http://tinyurl.com/ophthstemcells-update4

Copyright © 2008 Eye Doc Talk. All rights reserved.